Methylcobalamin Information & Coordination for Licensed U.S. Clinics

Methylcobalamin is a form of vitamin B12 with a different FDA regulatory record from cyanocobalamin.

Phoenix Meds Inc. supports licensed U.S. healthcare organizations with clinic verification, documentation organization, access to publicly available regulatory information, and administrative pharmacy coordination with independent licensed pharmacies.

For clinics reviewing a methylcobalamin inquiry, the specific B12 form, formulation, labeling, pharmacy documentation, and current FDA context all matter.

What Licensed Clinics Should Know About Methylcobalamin

Methylcobalamin is one of several forms, or vitamers, of vitamin B12.

FDA’s 2021 Pharmacy Compounding Advisory Committee materials distinguished methylcobalamin from cyanocobalamin and hydroxocobalamin. Those materials stated that methylcobalamin was not a component of FDA-approved products, while cyanocobalamin and hydroxocobalamin were components of approved products.

For clinic teams, the specific B12 form, formulation, labeling, dispensing entity, and supporting documentation should therefore be reviewed rather than relying on the general term “vitamin B12.”

Browse our medication information hub for other methylcobalamin related resources.

methylcobalamin B12 injection

Current FDA and 503A Context

FDA currently lists methylcobalamin in Category 1 — Bulk Drug Substances Under Evaluation for section 503A.

FDA defines Category 1 as substances that may be eligible for inclusion on the 503A Bulks List, were nominated with sufficient supporting information for FDA to evaluate them, and remain under evaluation.

Category 1 status is not FDA approval and does not mean methylcobalamin has been finally added to the 503A Bulks List.

FDA presented methylcobalamin to the Pharmacy Compounding Advisory Committee in 2021 and proposed that it not be included on the list. The committee voted 9–5 in favor of recommending inclusion.

That recommendation was advisory. FDA retains regulatory decision-making authority, and its May 14, 2026 materials continue to list methylcobalamin in Category 1 as a substance under evaluation

How Phoenix Meds Supports Methylcobalamin Inquiries

A professional methylcobalamin inquiry can involve clinic credentials, formulation details, pharmacy records, labeling, and questions about the current regulatory record. Phoenix Meds helps bring those administrative pieces together. Our support may include:

  • clinic and provider credential verification;
  • organization of available formulation and pharmacy documentation;
  • access to publicly available FDA and licensing information;
  • administrative pharmacy coordination; and
  • follow-up when supporting records require clarification.

This helps clinic teams keep credentials, documentation, regulatory information, and follow-up in one organized administrative record while licensed professionals remain responsible for prescribing, compounding, dispensing, and product-specific decisions.

Documentation and Due Diligence

For a methylcobalamin-related inquiry, relevant records may include:

  • the specific B12 form identified in the preparation;
  • concentration and formulation details;
  • labeling;
  • pharmacy or facility information;
  • available lot or batch records;
  • certificates of analysis or other pharmacy-provided documents, when available; and
  • relevant FDA or licensing information.
Phoenix Meds can organize available records for professional review and flag documentation that may require follow-up. We do not independently test or certify identity, purity, potency, sterility, stability, safety, effectiveness, or regulatory compliance.

Methylcobalamin Administrative Coordination for Licensed Clinics

Complete the Inquiry Form to begin clinic verification for a professional Methylcobalamin B12 inquiry. This service is available to licensed medical clinics and other authorized healthcare organizations.

Clinic Verification

Licensed healthcare organizations may submit professional and facility credentials for administrative verification.

Documentation Review

Once approved, select Methylcobalamin B12 from the category within our secure portal to view available coordination pathways.

Pharmacy Coordination

Where appropriate, Phoenix Meds can support administrative pharmacy coordination between a verified licensed clinic and an independent licensed pharmacy. The pharmacy remains responsible for its own professional, product-specific, compounding, dispensing, and regulatory decisions.

Frequently Asked Questions

FDA’s 2021 Pharmacy Compounding Advisory Committee materials stated that methylcobalamin was not a component of FDA-approved products. FDA currently lists methylcobalamin as a Category 1 bulk drug substance under evaluation for section 503A.
FDA’s May 14, 2026 document lists methylcobalamin in Category 1. This means it remains under evaluation. Category 1 status is not FDA approval or final inclusion on the 503A Bulks List.
Phoenix Meds supports clinic verification, documentation organization, publicly available regulatory information, and administrative pharmacy coordination.
Yes. We can organize available formulation, labeling, pharmacy-provided, lot or batch, and regulatory records.
No. Phoenix Meds does not manufacture, compound, prescribe, dispense, sell, ship, test, or take custody of medications. Those functions remain with the appropriately licensed entities responsible for performing them.

For order status and coordination, you can contact Phoenix Meds Inc.
For shipping events, damage, discrepancies, returns, adverse events, or recall notices, the licensed fulfilling partner will provide the official instructions and process. We can help coordinate communication so issues are resolved efficiently.

Important Notice

Phoenix Meds Inc. provides administrative coordination and documentation support for licensed U.S. healthcare organizations.

We are not a pharmacy, medical practice, manufacturer, wholesaler, distributor, prescriber, or dispensing entity.

Information on this page is provided for professional and administrative purposes and does not constitute medical or legal advice, a prescribing recommendation, FDA approval, or a product-specific regulatory determination.

Scroll to Top

Thank You!

Your order has been placed successfully.

Order Number #14327
Date May 19, 2025
Payment Method Credit Card (Stripe)
Please look out for an email from FedEx when your order ships.
Continue Shopping  ›